Loading...
Thumbnail Image
Publication

Considerations for Management of Longitudinal Melanonychia During the COVID-19 Pandemic: An International Perspective

Lipner, Shari R.
Iorizzo, Matilde
Jellinek, Nathaniel
Piraccini, Bianca Maria
Scher, Richard K.
Embargo Expiration Date
Abstract

To the editor: 34 Longitudinal melanonychia (LM) is the presenting sign of nail unit melanoma (NUM) in 2/3 35 of cases and is therefore among the most important conditions managed by dermatologists. In 36 normal times, referral for LM would prompt an expedited appointment for clinical 37 examination and dermoscopy.1 However, due to SARS-CoV-2, dermatologists have been 38 asked to reconsider “urgent/emergency” conditions. The COVID-19 pandemic has propelled 39 physicians to unexpectedly adopt telemedicine without adequate guidance for managing LM 40 patients.

Source

Lipner SR, Iorizzo M, Jellinek N, Piraccini BM, Scher RK. Considerations for Management of Longitudinal Melanonychia During the COVID-19 Pandemic: An International Perspective. J Am Acad Dermatol. 2020 May 13. doi: 10.1016/j.jaad.2020.05.028. Epub ahead of print. PMID: 32405124; PMCID: PMC7217794. Link to article on publisher's site

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1016/j.jaad.2020.05.028
PubMed ID
32405124
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
© 2020 by the American Academy of Dermatology. This is a PDF file of an accepted manuscript that has been accepted for publication and posted with a 12-month embargo and CC BY-NC-ND license as allowed by the publisher's author rights policy at https://www.elsevier.com/about/policies/sharing.